Uroplasty Reports Continued Progress During Second Quarter of F...( Share-based consulting expense ...),Health
Share-based consulting expense 36,409 26,005
Share-based compensation expense 453,592 644,637
Deferred income taxes (10,164) 2,474
Deferred rent (17,500) (17,500)
Changes in operating assets and liabilities:
Accounts receivable 537,959 (498,578)
Inventories (11,128) (16,176)
Other current assets and income tax
receivable (108,041) 64,660
Accounts payable (145,610) 190,508
Accrued liabilities (634,851) (80,460)
Accrued pension liability, net (44,772) (305,435)
Net cash used in operating activities (340,082) (1,688,197)
Cash flows from investing activities:
Proceeds from sale of short-term
investments 8,808,304 1,800,000
Purchase of short-term investments (7,891,373) (1,200,000)
Purchases of property, plant and equipment (130,421) (135,984)
Proceeds from sale of equipment - 4,417
Payments for intangible assets - (89,725)
Net cash provided by investing activities 786,510 378,708
Cash flows from financing activities:
Proceeds from financing obligations - 178,374
Repayment of debt obligations (455,913) (184,458)
Net proceeds from issuance of
common stock, warrants and option exercise - 768,298
Net cash provided by (used in) financing
activities (455,913) 762,214
Effect of exchange rates on c
'/>"/>
| SOURCE Uroplasty, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Uroplasty to Present at the Noble Financial Fourth Annual Equity Conference
2. Uroplasty to Host First Quarter Conference Call on July 31
3. Uroplasty Joins the Russell Microcap Index
4. Uroplasty Reports Record Growth for the Fourth Quarter and Fiscal Year 2008
5. Uroplasty to Host Fourth Quarter and Year End Conference Call on June 3
6. Uroplasty to Highlight Urgent PC System at American Urological Association 2008 Annual Meeting
7. Uroplasty Plans to Double Sales Force During Fiscal 2009
8. Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium
9. Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference
10. Uroplasty Expands Marketing Program for Urology Practices
11. Uroplasty, Inc. Announces Pricing of a Public Offering of Its Common Stock
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |